GEO series
S1P/S1PR4 Promotes the Differentiation of CD8+TRM Cells Aggravating Bile Duct Injury in Biliary Atresia
GSE300457
Homo sapiens
Expression profiling by high throughput sequencing
45 samples
2025/12/19
GPL24676
Summary
BACKGROUND AND AIMS: Biliary atresia (BA) is the most common and serious neonatal biliary disease, characterized by progressive biliary inflammation and fibrosis. We aim to comprehensively and systematically investigate the complex pathological process of BA from multiple molecular dimensions, combining transcriptomics, proteomics, metabolomics, and single-cell RNA sequencing. METHODS: Integration of multi-omics data detected and localized aberrant metabolite regulation in immune cells of BA liver tissue. By flow cytometry sorting of specific immune cell subsets and in vitro experiments, we verified the role and mechanism of the aberrant metabolite signaling pathway in the progression of BA. In vivo experiments confirmed the effect of inhibiting the aberrant signaling pathway in alleviating bile duct injury and fibrosis. RESULTS: Based on multi-omics data, the sphingolipid metabolism pathway was abnormally activated in the S1 subtype of BA, a molecular subtype characterized by abnormal immune inflammation and poor prognosis. By integrating single-cell RNA profiling, Sphingosine-1-Phosphate Receptor 4 (S1PR4), a receptor of Sphingosine-1-Phosphate (S1P), was primarily expressed in CX3CR1+CD8+effector T (Teff) cells. In vitro, S1P/S1PR4 signaling promoted the migration of CX3CR1+CD8+Teff cells, and facilitated the differentiation of CX3CR1+CD8+Teff cells into CD8+ tissue-resident memory T (TRM) cells. Co-culture of CD8+TRM cells and cholangiocytes could induce the apoptosis of cholangiocytes. In vivo, S1PR4 inhibitor could alleviate liver inflammation and fibrosis by inhibiting the accumulation of CD8+TRM cells. CONCLUSIONS: Our study revealed that activation of the S1P/S1PR4 signaling pathway promotes the differentiation of CD8+ TRM cells, which subsequently induces cholangiocyte injury. Targeting the activation of the S1P/S1PR4 signaling pathway is a promising therapeutic strategy for BA, especially for patients with the S1 subtype.
Download
NCBI GEO page ↗
Paper (PMID 40915360) ↗
{# Names what the click gives you. "Open in finder" meant nothing to a
visitor who arrived from a search engine and has never seen the tool. #}
Find more
human RNA-seq datasets →
Similar datasets
- GSE328275 Single-cell RNA sequencing of CD45+ immune cells across primary tumor, sentinel tumor-draining lymph node, and axillary lymph node in treatment-naive triple-negative breast cancer 28 samples
- GSE341753 Cohesin loading at regulatory elements shapes 3D genome folding during erythropoiesis [RNA-Seq] 12 samples
- GSE319969 Spatial and Bulk Transcriptomic Profiling Defines the Molecular Evolution of Cutaneous Squamous Cell Carcinoma and Reveals Stage-Specific Biomarkers of Clinical Relevance [RNA-Seq] 24 samples
- GSE313035 METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin 67 samples
- GSE342462 Integrated transcriptomic and bioelectrical profiling of stem-like cellular states in a colorectal cancer using SdFFF and UHF-DEP 12 samples
- GSE339456 Integrated bulk and spatial transcriptomic analysis identifies progression-associated molecular signatures in biopsy-proven hypertensive nephropathy [RNA-seq] 35 samples
- GSE199939 Comprehensive transcriptomic analysis of immune-related genes in diabetic foot ulcers: New insights into mechanisms and therapeutic targets 21 samples
- GSE336982 Obesity Promotes Lung Carcinogenesis Through Airway Immune Dysfunction 183 samples
Share this dataset
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.